BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Weil C, Nwankwo C, Friedman M, Kenet G, Chodick G, Shalev V. Epidemiology of hepatitis C virus infection in a large Israeli health maintenance organization: Epidemiology of Hepatitis C in a large Israeli HMO. J Med Virol 2016;88:1044-50. [DOI: 10.1002/jmv.24426] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Agmon S, Gillis P, Horvitz E, Radinsky K. Gender-sensitive word embeddings for healthcare. J Am Med Inform Assoc 2021:ocab279. [PMID: 34918101 DOI: 10.1093/jamia/ocab279] [Reference Citation Analysis]
2 Coppola N, Alessio L, Onorato L, Sagnelli C, Macera M, Sagnelli E, Pisaturo M. Epidemiology and management of hepatitis C virus infections in immigrant populations. Infect Dis Poverty 2019;8:17. [PMID: 30871599 DOI: 10.1186/s40249-019-0528-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
3 Xie Z, Xiao Z, Wang F. Hepatitis C Virus Nonstructural 5A Protein (HCV-NS5A) Inhibits Hepatocyte Apoptosis through the NF-κb/miR-503/bcl-2 Pathway. Mol Cells 2017;40:202-10. [PMID: 28343379 DOI: 10.14348/molcells.2017.2299] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
4 Ghaderi-Zefrehi H, Gholami-Fesharaki M, Sharafi H, Sadeghi F, Alavian SM. The Distribution of Hepatitis C Virus Genotypes in Middle Eastern Countries: A Systematic Review and Meta-Analysis. Hepat Mon. 2016;16:e40357. [PMID: 27826320 DOI: 10.5812/hepatmon.40357] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 4.3] [Reference Citation Analysis]
5 Schonmann Y, Yeshua H, Bentov I, Zelber-Sagi S. Liver fibrosis marker is an independent predictor of cardiovascular morbidity and mortality in the general population. Dig Liver Dis. 2021;53:79-85. [PMID: 33144054 DOI: 10.1016/j.dld.2020.10.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
6 Goldshtein I, Chodick G, Kochba I, Gal N, Webb M, Shibolet O. Identification and Characterization of Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol 2020;18:1887-9. [PMID: 31404663 DOI: 10.1016/j.cgh.2019.08.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Leventer-Roberts M, Dagan N, Berent JM, Brufman I, Hoshen M, Braun M, Balicer RD, Feldman BS. Using population-level incidence of hepatitis C virus and immigration status for data-driven screening policies: a case study in Israel. J Public Health (Oxf) 2020:fdaa215. [PMID: 33348364 DOI: 10.1093/pubmed/fdaa215] [Reference Citation Analysis]
8 Weil C, Mehta D, Koren G, Pinsky B, Samp JC, Chodick G, Shalev V. Sustained virological response to ombitasvir/paritaprevir/ritonavir and dasabuvir treatment for hepatitis C: Real-world data from a large healthcare provider. J Viral Hepat 2018;25:144-51. [PMID: 28984012 DOI: 10.1111/jvh.12800] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
9 Gold E, Mizrachi Y, Shalev A, Farhi J, Horowitz E, Ravhon A, Alush S, Levran D, Raziel A, Weissman A. Screening for blood born viruses in assisted reproduction: is annual testing necessary? Arch Gynecol Obstet 2019;299:1709-13. [PMID: 30874949 DOI: 10.1007/s00404-019-05112-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
10 Avisar N, Heller Y, Weil C, Ben-Baruch A, Potesman-Yona S, Oren R, Chodick G, Shalev V, Ash N. Multi-disciplinary patient-centered model for the expedited provision of costly therapies in community settings: the case of new medication for hepatitis C. Isr J Health Policy Res 2017;6:46. [PMID: 28954630 DOI: 10.1186/s13584-017-0172-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
11 Berg MG, Olivo A, Forberg K, Harris BJ, Yamaguchi J, Shirazi R, Gozlan Y, Sauleda S, Kaptue L, Rodgers MA, Mor O, Cloherty GA. Advanced molecular surveillance approaches for characterization of blood borne hepatitis viruses. PLoS One 2020;15:e0236046. [PMID: 32678844 DOI: 10.1371/journal.pone.0236046] [Reference Citation Analysis]